Phitonex

About:

Phitonex is developing the next generation of fluorescent labels and instrumentation to advance the fight against disease.

Website: http://www.phitonex.com/

Twitter/X: phitonex

Top Investors: CAV Angels

Description:

Phitonex, Inc. is developing the next generation of fluorescent labels and instrumentation to advance the fight against disease. Phitonex reagents provide a cost-effective, non-destructive method to obtain more information about critical molecular biomarkers, simplifying experimental design and accelerating the discovery process. As a Duke University spin-out, the company’s co-founders have over 15 years of collaborative experience engineering labels at the molecular level to tailor their fluorescence properties.

Total Funding Amount:

$2.18M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2017-01-01

Founders:

Alvin Lebeck, Chris Dwyer, Craig LaBoda

Number of Employees:

1-10

Last Funding Date:

2019-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai